Studies of the Pharmacodynamics and Modes of Action of Anthelmintic Drugs

Total Page:16

File Type:pdf, Size:1020Kb

Studies of the Pharmacodynamics and Modes of Action of Anthelmintic Drugs Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. · . STUDIES OF THE PHARMACODYNAMICS AND MODES OF ACTION OF ANTHELMINTIC DRUGS A THESIS PRESENTED IN PARTIAL FULFILMENT OF THE REQU IREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY AT MASSEY UNIVERS ITY U MIN SOE 1977 ii Abstract' of a thesis presented in partial fulfilment of the requirements for the Degree of Doctor of Ph ilosophy STUDIES OF THE PHARMACODYNAMICS AND MODES OF ACTION OF ANTHELMINTIC DRUGS by U MIN SOE 'ltl,e aim of this work is to extend existing knowledge both with respect to the mode of action of anthelmintics and the biochemical and physiological mechanisms which may be disrupted by drug action . The helminth species examined include nematodes , Ascari s suum, Ascaridia ga lli and Tr ichuris ovi s and cestodes , Moniezio" T. hyda tigena , T. taeni reformis and Echinoccocus granulosus; the anthelmintics studied were methyridine , diethylcarbamazine , pyrantel , morantel, tetramisole , levamisole , dichlorvos, vincofos , cambendazole and mebendazole . The helminth characteristics selected for most intensive study are (a) the occurrence and properties of helminth cholinesterase and (b) the uptake of glucose. The breadth of the study was limited by the availability of fresh material and not all combinations of helminth and drug were investigated. The histochemical localisation of cholinesterase activity in whole mounts and sections of tapeworms using thiocholine esters revealed a complex network of tegumental receptors feeding a nervous system with efferents to suckers , rostellum and hook mu scles. It is suggested tha t tapeworms have re flex arcs involving these struc tures allowing them to maintain their position in the host intestine in spite of peris taltic action . Th ese arcs are susceptible to anticholinesterase anthelmintics . Other cholinesterase activi ty is associated with the scolex , cirrus , genital pore and sometimes the tegument. High cholinesterase specific activities against acetylthiocholine were measured in Echinococcus scoleces and tapeworms , but lower leve ls in nematodes. Differential centrifugation of homogenates was used to iii study their occurrence in the tis sue and facilitate further characterisation . However, the enzyme was widely distributed in these species although somewhat higher in the particulate fractions. Ac tivity was increased little , if any, by attempts to solubilise it with the detergent, Triton X-IOO. Cholinesterase in some fractions particularly from T. ovis , had a high tempe rature optimum around 600C, but never showed the phenomenon of autoinhibition by substrate at concentrations up to IO-2M. Cholinesterase in species of worm with high levels of en zyme was more sensitive to eserine inhibition than those with lower levels. In studies of glucose uptake from the medium by As caris and two tapeworms , it was confirmed that transport into Ascaris was strongly inhibited by certain benzimidazole anthelmintics. Transport into Ascaris , bu t not the cestodes, was also discovered to be sensitive to local anaesthetics such as procaine or lignocaine . Uptake into tapeworms was inhibited by the absence of sodium ions , phlorizin, iodoacetate and dinitrophenol. It was less inhibited by benzimidazoles and not at all by organophosphate anthelmintics , but was sensitive to phenolic drugs such as hexachlorophene and nitroxynil . In the dog and sheep , a number of anthelmintic drugs administered intravenously showed predominantly nicotinic effects on blood pressure and respiration supporting the cholinergic action of these drugs . Although sheep red-cell cholinesterase is more sensitive to inhibition than that of all helminths tested , the oral route of administration of anthelmintics remains safe for the host and effective against intestinal parasitic worms . iv ACKNOWLEDGMENT I wish to express my gratitude to my chief supervisor D1·L. S. Forbes, who proposed the area of research covered in this thesis and for his suggestions and criticism and for the arrangements which were made for bringing this thesis to completion . I am greatly indebted to my other supervisor , Dr.R.M. Greenway for hi s role in supervision , continued interest, and never-failing support and encouragement. I have much pleasure in expressing my grateful thanks to Professor R.E. Munford , Head of the Department of Physiology and Anatomy , Massey University, for his computing and statistical analysis and the provision of laboratory facilities. I wish to express my gratitude to Dr. D.O. Heath and staff at Wallaceville Animal Re search Centre , We llington , for supplying T. ovis cysts and for valuable suggestions. I am indebted to Mrs Sharon Pickett for her technical assistance and typing of my manuscript and Mrs Fay Wicherts for her careful final typing . The enthusiastic technical assistance of Messrs R.N. Ward , B. O'Sullivan , and R. Te lfer and our photographer , Mr T. Law are warmly appreciated . Acknowledgements are due to the staff of the library , especially Miss E.M. Green, from the interloan section of the library at Massey University , for facilities in verifying the references from different libraries throughout New Zealand and overseas . This investigation ha s been financially supported by the Burmese Government and the New zealand Government under bilateral aid arrangement of Colombo Plan Scholarship and I am much indebted to both Governments . Finally , I thank my mother Daw Kyaw Shin , who was deceased during the course of my studies , in Burma , for her upbringing and persistant encouragement and then my wife Kyi Kyi Nyunt and our son , Soe Wunna for their encouragement during our separation for the five years while I was engaged in this research in New zealand . v CONTENTS Page No CHAPTER 1 The significance of helminth infections and their control 1 CHAPTER 2 M9de s of action of anthelmintics 6 CHAPTER 3 Pharmacodynamic studies related to anthelmintic action and their effects on host cholinesterase 37 CHAPTER 4 Helminth cholines terase and the influence of inhibitors and anthelmintics 77 CHAPTER 5 Helminth glucose uptake and the influence of inhibitors and anthelmintics 180 CHAPTER 6 Helminth cholinesterase: Histochemical studies and the influence of inhibitors 241 GENE RAL DISCUSSION 285 REFERENCES AND ADDENDUM 287 1 1.0 CHAPTER 1 THE SIGNIFICANCE OF HELMINTH INFECTIONS AND THEIR CONTROL 1.1 THE GLOBAL SIG NIFICANCE OF HELMINTH DISEASE 1.2 CHEMOTHERAPY AND ANTHELMINTICS 1.3 HELMINTH CONTROL BY DRUGS 1.4 DEVELOPMENT OF NEW ANTHELMINTICS 1.5 SIGNIFICANCE OF THE PRESENT RESEARCH / 2. 1.1 THE SIGNIFICANCE OF HELMINTH INFECTIONS AND 1. THE IR CONTROL 1.1 THE GLOBAL SIGNIFICANCE OF HELMINTH DISEASE Because of the need for brevity only a few generalisations can be made concerning the overall relation of helminth disease to world health and live stock production. In man , the major problems are undoubtedly located in tropical and sub-tropical areas where climatic , ecological, sociological and other factors combine to favour persistance and spread of parasite helminths , and in large areas of the world almost all the indigenous populations may be infected with such serious and debilitating conditions as bilharziasis (schistosomiasis) and hookworm disease (Wilson and Schild , 1959) . The topic has been dealt with dramatic­ ally in the classic treatise 'This Wormy World ' (Stoll , 1947) . Some relevant data are given in Table 1.1 TABLE 1.1. SHOWING THE EXTENT OF SOME HELMINTH INFECTION IN MAN * Infections Number of infections References (x 106 ) Total number of infections 2250 Stoll (1947) Number of people infected 800 Ditto Ascaris lumbri coides 644 Ditto Hookworm 456 .8 Ditto Tr ichuris trichiura 355 Ditto Enterobius vermi cularis 208 .8 Ditto schistosoma 114 Ditto Fi lariae 304 Ditto Schistosoma ja ponicum (China ) 33 Slack & Nineham (1968) s. haema tobium and S. Mansoni 12 Ditto (Egypt) S. haema tobium (West and Central AFrica) 8.5 Ditto S. Mansoni (Brazil) 4.0 Ditto 6 * To tal world population 21§6 x 10- 3 1.3 In contrast to man, the ma in helminth problems associated with livestock production appear in temperate regions and are related particularly to deve lopme nt of highly stocked grasslands and intensive poultry and pig production units . The global economic loss arising from mortali ties, inhibi ted production and associated with development and , application of control measures, is a matter for conjecture - but must easily amount to billions of dollars annually . 1.2 CHEMOTHERAPY AND ANTHELMINTICS As in the case of infection by all small or microscopic pathogenic organisms, the main line of therapeutic defence lies in utilising the selective toxicity of suitable drugs against the pathogen. The term selective toxicity was introduced by Albert (1977) to embrace the use of chemical substances to destroy or inhibit an unwanted species (the uneconomic species) while, at the same time, causing little or no harm to a closely associated desirable species (the economic species). In medicine, the economic species may be man or some other desired animal - whereas the uneconomic species may be a virus, bacterium, fungus, protozoan, helminth parasite or neoplastic cell . In this context the use of drugs with the ob ject of causing maximal injury to the pathogen or neoplasm and minimal harm to the host is described as chemotherapy . Anthelmintics are drugs
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Download Download
    MM Matin et al. Medical Research Archives vol 8 issue 7. Medical Research Archives RESEARCH ARTICLE 2e`1 PASS Predication, Antiviral, in vitro Antimicrobial, and ADMET Studies of Rhamnopyranoside Esters Authors Mohammed M Matin1, Mohammad HO Roshid2, Sreebash C Bhattacharjee3 and Abul KMS Azad4 Affiliations 1 Bioorganic & Medicinal Chemistry Laboratory, Department of Chemistry, University of Chittagong, Chattogram-4331, Bangladesh 2 Department of Anaesthesia and Intensive Care Medicine, Chattogram Medical College, Chattogram- 4203, Bangladesh 3 Chemical Research Division, Bangladesh Council of Scientific & Industrial Research (BCSIR) Laboratories, Chattogram-4220, Bangladesh 4 Department of Chemistry, Chattogram Govt. College, Chattogram-4203, Bangladesh Corresponding Author: MM Matin E-mail address: [email protected] Tel.: +88 01716 839689. Abstract Sugar derived esters (SEs) with potential antimicrobial activity were found to be a better choice to solve the multidrug resistant (MDR) pathogens due to improved antimicrobial efficacy, biodegradability, non-toxic, and non-allergic properties. In this context, a series of benzyl -L- rhamnopyranoside esters with different chain length (C2-C18) were employed for PASS predication, antiviral, and in vitro antimicrobial activity test. The in vitro antimicrobial tests against four bacterial, and four fungal pathogens along with PASS predication indicated that these sugar esters acted as better antifungals as compared to antibacterial functionality. The study revealed that the incorporation of octanoyl (C8) and lauroyl (C12) group(s) at C-3 position of rhamnopyranoside possessed promising antimicrobial, and anti-carcinogenic potentiality with good pharmacokinetic (pkCSM), and drug likeness properties. Also, attachment of multiple ester groups enhanced various drug likeness, and medicinal chemistry friendliness conditions. Overall, the present findings might be useful for the development of rhamnopyranoside based novel MDR antimicrobial drugs.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • B-Lactams: Chemical Structure, Mode of Action and Mechanisms of Resistance
    b-Lactams: chemical structure, mode of action and mechanisms of resistance Ru´ben Fernandes, Paula Amador and Cristina Prudeˆncio This synopsis summarizes the key chemical and bacteriological characteristics of b-lactams, penicillins, cephalosporins, carbanpenems, monobactams and others. Particular notice is given to first-generation to fifth-generation cephalosporins. This review also summarizes the main resistance mechanism to antibiotics, focusing particular attention to those conferring resistance to broad-spectrum cephalosporins by means of production of emerging cephalosporinases (extended-spectrum b-lactamases and AmpC b-lactamases), target alteration (penicillin-binding proteins from methicillin-resistant Staphylococcus aureus) and membrane transporters that pump b-lactams out of the bacterial cell. Keywords: b-lactams, chemical structure, mechanisms of resistance, mode of action Historical perspective Alexander Fleming first noticed the antibacterial nature of penicillin in 1928. When working with Antimicrobials must be understood as any kind of agent another bacteriological problem, Fleming observed with inhibitory or killing properties to a microorganism. a contaminated culture of Staphylococcus aureus with Antibiotic is a more restrictive term, which implies the the mold Penicillium notatum. Fleming remarkably saw natural source of the antimicrobial agent. Similarly, under- the potential of this unfortunate event. He dis- lying the term chemotherapeutic is the artificial origin of continued the work that he was dealing with and was an antimicrobial agent by chemical synthesis [1]. Initially, able to describe the compound around the mold antibiotics were considered as small molecular weight and isolates it. He named it penicillin and published organic molecules or metabolites used in response of his findings along with some applications of penicillin some microorganisms against others that inhabit the same [4].
    [Show full text]
  • Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
    REVIEW published: 03 July 2018 doi: 10.3389/fmicb.2018.01367 Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis Diana Machado 1, Miriam Girardini 2, Miguel Viveiros 1* and Marco Pieroni 2* 1 Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Lisbon, Portugal, 2 P4T Group, Department of Food and Drug, University of Parma, Parma, Italy The emergence of multi- and extensively drug resistant tuberculosis worldwide poses a great threat to human health and highlight the need to discover and develop new, effective and inexpensive antituberculosis agents. High-throughput screening assays Edited by: against well-validated drug targets and structure based drug design have been employed Fernando Rogerio Pavan, to discover new lead compounds. However, the great majority fail to demonstrate any Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Brazil antimycobacterial activity when tested against Mycobacterium tuberculosis in whole-cell Reviewed by: screening assays. This is mainly due to some of the intrinsic properties of the bacilli, Pedro Almeida Silva, such as the extremely low permeability of its cell wall, slow growth, drug resistance, Fundação Universidade Federal do drug tolerance, and persistence. In this sense, understanding the pathways involved Rio Grande, Brazil Luiz Augusto Basso, in M. tuberculosis drug tolerance, persistence, and pathogenesis, may reveal new Pontifícia Universidade Católica do Rio approaches for drug development. Moreover, the need for compounds presenting a Grande do Sul, Brazil novel mode of action is of utmost importance due to the emergence of resistance not *Correspondence: Miguel Viveiros only to the currently used antituberculosis agents, but also to those in the pipeline.
    [Show full text]
  • Mechanisms of Action for Small Molecules Revealed by Structural Biology in Drug Discovery
    International Journal of Molecular Sciences Review Mechanisms of Action for Small Molecules Revealed by Structural Biology in Drug Discovery Qingxin Li 1,* and CongBao Kang 2,* 1 Guangdong Provincial Engineering Laboratory of Biomass High Value Utilization, Guangdong Provincial Bioengineering Institute (Guangzhou Sugarcane Industry Research Institute), Guangdong Academy of Sciences, Guangzhou 510316, China 2 Experimental Drug Development Centre (EDDC), Agency for Science, Technology and Research (A*STAR), 10 Biopolis Road, Chromos, #05-01, Singapore 138670, Singapore * Correspondence: [email protected] (Q.L.); [email protected] (C.K.); Tel.: +86-020-84168436 (Q.L.); +65-64070602 (C.K.) Received: 12 June 2020; Accepted: 20 July 2020; Published: 24 July 2020 Abstract: Small-molecule drugs are organic compounds affecting molecular pathways by targeting important proteins. These compounds have a low molecular weight, making them penetrate cells easily. Small-molecule drugs can be developed from leads derived from rational drug design or isolated from natural resources. A target-based drug discovery project usually includes target identification, target validation, hit identification, hit to lead and lead optimization. Understanding molecular interactions between small molecules and their targets is critical in drug discovery. Although many biophysical and biochemical methods are able to elucidate molecular interactions of small molecules with their targets, structural biology is the most powerful tool to determine the mechanisms of action for both targets and the developed compounds. Herein, we reviewed the application of structural biology to investigate binding modes of orthosteric and allosteric inhibitors. It is exemplified that structural biology provides a clear view of the binding modes of protease inhibitors and phosphatase inhibitors.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
    USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO).
    [Show full text]
  • WO 2012/148799 Al 1 November 2012 (01.11.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/148799 Al 1 November 2012 (01.11.2012) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 9/107 (2006.01) A61K 9/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A 61 47/10 (2006.0V) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, PCT/US2012/034361 HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (22) International Filing Date: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 20 April 2012 (20.04.2012) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/480,259 28 April 201 1 (28.04.201 1) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (71) Applicant (for all designated States except US): BOARD UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, OF REGENTS, THE UNIVERSITY OF TEXAS SYS¬ TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, TEM [US/US]; 201 West 7th St., Austin, TX 78701 (US).
    [Show full text]
  • Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer
    pharmaceutics Review Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer Sibusiso Alven, Xhamla Nqoro , Buhle Buyana and Blessing A. Aderibigbe * Department of Chemistry, University of Fort Hare, Alice Eastern Cape 5700, South Africa; [email protected] (S.A.); [email protected] (X.N.); [email protected] (B.B.) * Correspondence: [email protected] Received: 24 November 2019; Accepted: 30 December 2019; Published: 29 April 2020 Abstract: Cancer is a chronic disease that is responsible for the high death rate, globally. The administration of anticancer drugs is one crucial approach that is employed for the treatment of cancer, although its therapeutic status is not presently satisfactory. The anticancer drugs are limited pharmacologically, resulting from the serious side effects, which could be life-threatening. Polymer drug conjugates, nano-based drug delivery systems can be utilized to protect normal body tissues from the adverse side effects of anticancer drugs and also to overcome drug resistance. They transport therapeutic agents to the target cell/tissue. This review article is based on the therapeutic outcomes of polymer-drug conjugates against breast and lung cancer. Keywords: breast cancer; lung cancer; chemotherapy; polymer-based carriers; polymer-drug conjugates 1. Introduction Cancer is a chronic disease that leads to great mortality around the world and cancer cases are rising continuously [1]. It is the second cause of death worldwide, followed by cardiovascular diseases [2]. It is characterized by an abnormal uncontrolled proliferation of any type of cells in the human body [3]. It is caused by external factors, such as smoking, infectious organisms, pollution, and radiation; it is also caused by internal factors, such as immune conditions, hormones, and genetic mutation [3].
    [Show full text]
  • Comparative Genomics of the Major Parasitic Worms
    Comparative genomics of the major parasitic worms International Helminth Genomes Consortium Supplementary Information Introduction ............................................................................................................................... 4 Contributions from Consortium members ..................................................................................... 5 Methods .................................................................................................................................... 6 1 Sample collection and preparation ................................................................................................................. 6 2.1 Data production, Wellcome Trust Sanger Institute (WTSI) ........................................................................ 12 DNA template preparation and sequencing................................................................................................. 12 Genome assembly ........................................................................................................................................ 13 Assembly QC ................................................................................................................................................. 14 Gene prediction ............................................................................................................................................ 15 Contamination screening ............................................................................................................................
    [Show full text]
  • What Is Medicinal Chemistry
    Unit 1 Prepared By: Neetu Sabarwal Department of Pharmaceutical Chemistry SOS Pharmaceutical Sciences Jiwaji University. Gwalior Content INTRODUCTION TO MEDICINAL CHEMISTRY • History and development of medicinal chemistry Physicochemical properties in relation to biological action • Ionization, Solubility, Partition Coefficient, Hydrogen bonding, Protein binding, Chelation, • Bioisosterism, Optical and Geometrical isomerism. Drug metabolism • Drug metabolism principles- Phase I and Phase II. • Factors affecting drug metabolism including stereo chemical aspects. CHEMISTRY What is Chemistry? • Chemistry is known as the central of science. • It is a branch of physical science that studies the composition, structure, properties and changes of matter. • MATTER = Solid / Liquid/ Gas. BRANCHES OF CHEMISTRY PHYSICAL CHEMISTRY • the branch of chemistry concerned with the application of the techniques and theories of physics to the study of chemical systems. • Branches : chemical Kinetics, Electrochemistry, spectroscopy, photochemistry. INORGANIC CHEMISTRY • deals with the synthesis and behaviour of inorganic and organometallic compounds • Branches :Bioinorganic, Cluster, Material & Nuclear Chemistry ORGANIC CHEMISTRY • study of the structure, properties, and reactions of organic compounds and organic materials, i.e., matter in its various forms that contain carbon atoms. • Branches : Biochemistry, biophysical, Biorganic, P’ceutical, Medicinal WHAT IS MEDICINAL CHEMISTRY • It is a discipline or intersection of chemistry especially synthetic organic
    [Show full text]
  • Treatment of Parasitic Infestations in Reptiles
    Brim!, Herpetological Society Bulletin. No 8 1983 TREATMENT OF PARASITIC INFESTATIONS IN REPTILES K. LAWRENCE, BVSc, MRCVS 30 Beanhill Road, Ducklington, Wirney, Oxon OX8 7XX Ticks and mites both suck blood from the host reptile, this causes irritation, anaemia in the case of heavy infestations and the possible transmission of septacaemic bacterial disease (Camin 1948). Ticks are usually only found on freshly imported reptiles, they are large, easily seen and relatively immobile. If they are manually removed care must be taken to remove the whole tick and not to leave the mouthparts in situ, where they can act as a nidus of infection. The tick's mouthparts can be caused to loosen by applying liquid paraffin or a parasitocidal wash to the abdomen before any removal attempt. The site of attachment is cleansed with a suitable disinfectant such as Pevidene (Berk Pharmaceuticals) Mites are often a cause for greater concern with their ability to travel up to 15 feet per day facilitating their spread through a reptile collection. The life history of the Ophionyssus sp. of reptile mite has been dealt with by Palumbo (1971). Whilst bathing snakes in a parasitocidal wash such as 0.2% Alugan (Hoechst U.K. Ltd) is effective, the treatment of choice is dichlorvos in the form of a Vapona (Shellstar Consumer Products U.K.) strip. The directions on the packet must be followed and an appropriate sized portion of the strip placed in the vivarium, ensuring that the reptile can not come into direct contact with it. Jackson (1977) recommends a treatment schedule of 3 to 4 days although Rosenfeld (1975) found periods of up to 3 weeks proved necessary to effectively control mites in certain species of lizards.
    [Show full text]